Invesco’s X4 Pharmaceuticals XFOR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-58,187
| Closed | -$13.8K | – | 3879 |
|
2025
Q1 | $13.8K | Sell |
58,187
-3,886
| -6% | -$919 | ﹤0.01% | 3741 |
|
2024
Q4 | $45.5K | Sell |
62,073
-61,707
| -50% | -$45.3K | ﹤0.01% | 3682 |
|
2024
Q3 | $82.8K | Buy |
123,780
+25,200
| +26% | +$16.9K | ﹤0.01% | 3629 |
|
2024
Q2 | $57.2K | Sell |
98,580
-42
| -0% | -$24 | ﹤0.01% | 3794 |
|
2024
Q1 | $137K | Buy |
98,622
+2,196
| +2% | +$3.05K | ﹤0.01% | 3699 |
|
2023
Q4 | $80.9K | Buy |
96,426
+15,397
| +19% | +$12.9K | ﹤0.01% | 3699 |
|
2023
Q3 | $88.3K | Buy |
81,029
+9,471
| +13% | +$10.3K | ﹤0.01% | 3719 |
|
2023
Q2 | $139K | Buy |
71,558
+41,613
| +139% | +$80.7K | ﹤0.01% | 3663 |
|
2023
Q1 | $26.1K | Buy |
29,945
+14,331
| +92% | +$12.5K | ﹤0.01% | 3780 |
|
2022
Q4 | $15.5K | Buy |
+15,614
| New | +$15.5K | ﹤0.01% | 3966 |
|